These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29934907)

  • 1. Predicting Chemically Induced Skin Sensitization by Using In Chemico / In Vitro Methods.
    Rossi LH; Ezendam J
    Methods Mol Biol; 2018; 1800():485-504. PubMed ID: 29934907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
    Ezendam J; Braakhuis HM; Vandebriel RJ
    Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions.
    de Ávila RI; Lindstedt M; Valadares MC
    Regul Toxicol Pharmacol; 2019 Nov; 108():104445. PubMed ID: 31430506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The THP-1 cell toolbox: a new concept integrating the key events of skin sensitization.
    Clouet E; Bechara R; Raffalli C; Damiens MH; Groux H; Pallardy M; Ferret PJ; Kerdine-Römer S
    Arch Toxicol; 2019 Apr; 93(4):941-951. PubMed ID: 30806763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Martinozzi Teissier S; Nardelli L; Noçairi H; Pauloin T; Piroird C; Del Bufalo A
    Toxicol In Vitro; 2019 Oct; 60():134-143. PubMed ID: 31100378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro assays for the assessment of the skin sensitization hazard of functional polysiloxanes and silanes.
    Petry T; Bosch A; Coste X; Eigler D; Germain P; Seidel S; Jean PA
    Regul Toxicol Pharmacol; 2017 Mar; 84():64-76. PubMed ID: 28017767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of substances found positive in 1 of 3 in vitro tests for skin sensitization.
    Kolle SN; Natsch A; Gerberick GF; Landsiedel R
    Regul Toxicol Pharmacol; 2019 Aug; 106():352-368. PubMed ID: 31112722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification.
    Ramirez T; Mehling A; Kolle SN; Wruck CJ; Teubner W; Eltze T; Aumann A; Urbisch D; van Ravenzwaay B; Landsiedel R
    Toxicol In Vitro; 2014 Dec; 28(8):1482-97. PubMed ID: 25172300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of the KeratinoSens™ skin sensitization test to animal-product-free cell culture.
    Belot N; Sim B; Longmore C; Roscoe L; Treasure C
    ALTEX; 2017; 34(4):560-564. PubMed ID: 28403479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HaCaT/THP-1 Cocultured Activation Test (COCAT) for skin sensitization: a study of intra-lab reproducibility and predictivity.
    Eskes C; Hennen J; Schellenberger MT; Hoffmann S; Frey S; Goldinger-Oggier D; Peter N; Van Vliet E; Blömeke B
    ALTEX; 2019; 36(4):613-622. PubMed ID: 31132132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing skin sensitization hazard in mice and men using non-animal test methods.
    Urbisch D; Mehling A; Guth K; Ramirez T; Honarvar N; Kolle S; Landsiedel R; Jaworska J; Kern PS; Gerberick F; Natsch A; Emter R; Ashikaga T; Miyazawa M; Sakaguchi H
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):337-51. PubMed ID: 25541156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adverse outcome pathway concept: a pragmatic tool in toxicology.
    Vinken M
    Toxicology; 2013 Oct; 312():158-65. PubMed ID: 23978457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines.
    Kolle SN; Landsiedel R; Natsch A
    Regul Toxicol Pharmacol; 2020 Aug; 115():104713. PubMed ID: 32562760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.
    MacKay C; Davies M; Summerfield V; Maxwell G
    ALTEX; 2013; 30(4):473-86. PubMed ID: 24173169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporter cell lines for skin sensitization testing.
    Natsch A; Emter R
    Arch Toxicol; 2015 Oct; 89(10):1645-68. PubMed ID: 26194644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anchoring molecular mechanisms to the adverse outcome pathway for skin sensitization: Analysis of existing data.
    van der Veen JW; Soeteman-Hernández LG; Ezendam J; Stierum R; Kuper FC; van Loveren H
    Crit Rev Toxicol; 2014 Aug; 44(7):590-9. PubMed ID: 25000333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.
    van Vliet E; Kühnl J; Goebel C; Martinozzi-Teissier S; Alépée N; Ashikaga T; Blömeke B; Del Bufalo A; Cluzel M; Corsini E; Delrue N; Desprez B; Gellatly N; Giese C; Gribaldo L; Hoffmann S; Klaric M; Maillere B; Naisbitt D; Pallardy M; Vocanson M; Petersohn D
    ALTEX; 2018; 35(2):179-192. PubMed ID: 28968481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Defined Approaches for Skin Sensitization to Agrochemical Products.
    Strickland J; Truax J; Corvaro M; Settivari R; Henriquez J; McFadden J; Gulledge T; Johnson V; Gehen S; Germolec D; Allen DG; Kleinstreuer N
    Front Toxicol; 2022; 4():852856. PubMed ID: 35586187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin sensitization in silico protocol.
    Johnson C; Ahlberg E; Anger LT; Beilke L; Benigni R; Bercu J; Bobst S; Bower D; Brigo A; Campbell S; Cronin MTD; Crooks I; Cross KP; Doktorova T; Exner T; Faulkner D; Fearon IM; Fehr M; Gad SC; Gervais V; Giddings A; Glowienke S; Hardy B; Hasselgren C; Hillegass J; Jolly R; Krupp E; Lomnitski L; Magby J; Mestres J; Milchak L; Miller S; Muster W; Neilson L; Parakhia R; Parenty A; Parris P; Paulino A; Paulino AT; Roberts DW; Schlecker H; Stidl R; Suarez-Rodrigez D; Szabo DT; Tice RR; Urbisch D; Vuorinen A; Wall B; Weiler T; White AT; Whritenour J; Wichard J; Woolley D; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2020 Oct; 116():104688. PubMed ID: 32621976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.